Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

Rhea-AI Summary

Guardion Health Sciences (Nasdaq: GHSI) has announced a significant cash dividend of $5.00 per share of common stock. The company's Board of Directors declared this dividend for stockholders of record as of September 9, 2024, with the payment scheduled for September 23, 2024. This substantial dividend declaration suggests a strong financial position for Guardion and represents a notable return of value to shareholders. The announcement may have positive implications for investor confidence and could potentially impact the stock's performance in the near term.

Positive

• Substantial cash dividend of $5.00 per share declared
• Indicates strong financial position and ability to return value to shareholders
• Potential boost to investor confidence and stock attractiveness

Negative

• Large dividend payout may impact cash reserves for future operations or investments
• Potential short-term decrease in stock price post-dividend payment

HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash dividend in an amount equal to $5.00 per share of common stock held by its stockholders of record on September 9, 2024 and a payment date of September 23, 2024.

Forward-Looking Statements

The matters described herein may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements contain information about our expectations, beliefs, plans or intentions regarding our product development and commercialization efforts, research and development efforts, business, financial condition, results of operations, strategies or prospects, and other similar matters. Statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” “hopes” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could” are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. 

These statements are based on management’s current expectations and assumptions about future events, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict, and involve unknown risks and uncertainties that may individually or materially impact the matters discussed herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the completion of the Company’s Plan of Liquidation and Dissolution, the use of the proceeds received from the sale of the Viactiv business, the Company’s decision to continue to fund or wind-down its operations subsequent to the sale of the Viactiv business, the sale or other disposition of the Company’s ocular healthcare business, the exploration, timing and feasibility of alternatives to the Company’s Plan of Liquidation and Dissolution, the payment of a cash dividend on the Company’s common stock supply chain disruptions, a potential recession and the condition of the economy in general, the Company’s ability to successfully market its remaining products and inventory, and the Company’s ability to maintain compliance with Nasdaq’s continued listing requirements.

Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information about Guardion Health Sciences, Inc., Contact:

investors@guardionhealth.com

Phone: 1-800 873-5141 Ext 208

FAQ

What is the amount of the cash dividend declared by Guardion Health Sciences (GHSI)?

Guardion Health Sciences (GHSI) has declared a cash dividend of $5.00 per share of common stock.

When is the record date for Guardion Health Sciences' (GHSI) dividend?

The record date for Guardion Health Sciences' (GHSI) dividend is September 9, 2024.

What is the payment date for Guardion Health Sciences' (GHSI) $5.00 dividend?

The payment date for Guardion Health Sciences' (GHSI) $5.00 dividend is September 23, 2024.

How might the $5.00 dividend affect Guardion Health Sciences' (GHSI) stock price?

The $5.00 dividend may initially boost GHSI's stock price due to increased investor interest, but it could potentially decrease after the ex-dividend date as the stock price adjusts for the dividend payout.